Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis = Expression of Toll-like Receptors, Pro-, and Anti-inflammatory Cytokines in Relation to Gut Microbiota in Irritable Bowel Syndrome: The Evidence for Its Micro-organic Basis

다국어 초록 (Multilingual Abstract)

Background/Aims
A Subset of patients with irritable bowel syndrome (IBS) may have mild inflammation due to immune activation. Toll-like receptors (TLRs) and cytokines may cause intestinal inflammation. We studied their expression in relation to gut microbiota.
Methods
Expression of TLRs and cytokines was assessed in 47 IBS patients (Rome III) and 25 controls using quantitative real-time polymerase chain reaction. Immunohistochemistry was further performed to confirm the expression of TLR-4 and TLR-5.
Results
Of 47 patients with IBS, 20 had constipation (IBS-C), 20 diarrhea (IBS-D), and 7 unclassified (IBS-U). The mRNA levels of TLR-4 and TLR-5 were up-regulated in IBS patients than controls (P = 0.013 and P < 0.001, respectively). Expression of TLR-4 and TLR-5 at protein level was 4.2-folds and 6.6-folds higher in IBS-D than controls. The mRNA levels of IL-6 (P = 0.003), C-X-C motif chemokine ligand 11 (CXCL-11) (P < 0.001) and C-X-C motif chemokine receptor 3 (CXCR-3) (P < 0.001) were higher among IBS patients than controls. Expression of IL-6 (P = 0.002), CXCL-11 (P < 0.001), and CXCR-3 (P < 0.001) were up-regulated and IL-10 (P = 0.012) was down-regulated in IBS-D patients than controls. Positive correlation was seen between TLR-4 and IL-6 (P = 0.043), CXCR-3, and CXCL-11 (P = 0.047), and IL-6 and CXCR-3 (P = 0.003). Stool frequency per week showed positive correlation with mRNA levels of TLR-4 (P = 0.016) and CXCR-3 (P = 0.005), but inversely correlated with IL-10 (P = 0.002). Copy number of Lactobacillus (P = 0.045) and Bifidobacterium (P = 0.011) showed correlation with IL-10 in IBS-C, while Gram-positive (P = 0.031) and Gram-negative bacteria (P= 0.010) showed correlation with CXCL-11 in IBS-D patients.
Conclusions
Altered immune activation in response to dysbiotic microbiota may promote intestinal inflammation in a subset of patients with IBS.
(J Neurogastroenterol Motil 2018;24:628-642)

참고문헌 (Reference)

1 Schaefer TM, "toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells" 112 : 428-436, 2004

2 Wen-Jing Liang, "Tryptase and Protease-Activated Receptor 2 Expression Levels in Irritable Bowel Syndrome" 거트앤리버 발행위원회 10 (10): 382-390, 2016

3 Abreu MT, "Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function" 10 : 131-144, 2010

4 McKernan DP, "Toll-like receptor mRNA expression is selectively increased in the colonic mucosa of two animal models relevant to irritable bowel syndrome" 4 : e8226-, 2009

5 Means TK, "The toll-like receptor 5 stimulus bacterial flagellin induces maturation and chemokine production in human dendritic cells" 170 : 5165-5175, 2003

6 Tokuyama H, "The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfatemediated colitis" 17 : 1023-1034, 2005

7 Gribar SC, "The role of epithelial tolllike receptor signaling in the pathogenesis of intestinal inflammation" 83 : 493-498, 2008

8 Ipci K, "The possible mechanisms of the human microbiome in allergic diseases" 274 : 617-626, 2017

9 Ghoshal UC, "The gut microbiota and irritable bowel syndrome: friend or foe" 2012 : 151085-, 2012

10 Seth AK, "Successful colonoscopic fecal microbiota transplantation for active ulcerative colitis: first report from India" 35 : 393-395, 2016

11 De Silva AP, "Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting" 47 : 619-624, 2012

12 Schroepf S, "Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease" 16 : 1882-1890, 2010

13 Chang L, "Serum and colonic mucosal immune markers in irritable bowel syndrome" 107 : 262-272, 2012

14 Keszthelyi D, "Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome" 40 : 392-402, 2014

15 van der Veek PP, "Role of tumor necrosis factor-α and interleukin-10 gene polymorphisms in irritable bowel syndrome" 100 : 2510-2516, 2005

16 Belmonte L, "Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype" 7 : e42777-, 2012

17 Arebi N, "Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations" 28 : 830-840, 2008

18 Geiger B, "Resolving lesions in human cutaneous leishmaniasis predominantly harbour chemokine receptor CXCR3-positive T helper 1/T cytotoxic type 1 cells" 162 : 870-874, 2010

19 Borchers AT, "Probiotics and immunity" 44 : 26-46, 2009

20 Jardí F, "Plasticity of dorsal root ganglion neurons in a rat model of post-infectious gut dysfunction: potential implication of nerve growth factor" 49 : 1296-1303, 2014

21 Kerckhoffs AP, "Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients" 15 : 2887-2892, 2009

22 Bao CR, "Lentivirus-mediated gene transfer of small interfering RNA against the chemokine receptor CXCR3 suppresses cytokine indicators of acute graft rejection in a rat model" 38 : 1113-1120, 2010

23 O’Mahony L, "Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles" 128 : 541-551, 2005

24 Ortiz-Lucas M, "Irritable bowel syndrome immune hypothesis. Part two: the role of cytokines" 102 : 711-717, 2010

25 Danese S, "Interleukin-6: a therapeutic Jekyll and Hyde in gastrointestinal and hepatic diseases" 59 : 149-151, 2010

26 Subramanyam C, "Influence of probiotic administration on the fecal microbiota in diarrhea-predominant irritable bowel syndrome" 34 : 275-276, 2015

27 Hida N, "Increased expression of IL- 10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration" 52 : 658-664, 1999

28 Hughes PA, "Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms" 108 : 1066-1074, 2013

29 Kimang’a A, "IL-17A and IL-17F gene expression is strongly induced in the mucosa of H. pylori-infected subjects from Kenya and Germany" 72 : 522-528, 2010

30 Frosali S, "How the intricate interaction among toll-like receptors, microbiota, and intestinal immunity can influence gastrointestinal pathology" 2015 : 489821-, 2015

31 Hajela N, "Gut microbiome, gut function, and probiotics: implications for health" 34 : 93-107, 2015

32 Vaishnavi C, "Fecal microbiota transplantation for management of Clostridium difficile infection" 33 : 301-307, 2014

33 Shukla R, "Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis" 60 : 2953-2962, 2015

34 Xu J, "Expression of toll-like receptors and their association with cytokine responses in peripheral blood mononuclear cells of children with acute rotavirus diarrhoea" 144 : 376-381, 2006

35 Wells JM, "Epithelial crosstalk at the microbiota-mucosal interface" 108 (108): 4607-4614, 2011

36 Ghoshal UC, "Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian society of gastroenterology task force" 27 : 22-28, 2008

37 Chang L, "Dysregulation of the hypothalamic- pituitary-adrenal (HPA) axis in irritable bowel syndrome" 21 : 149-159, 2009

38 Brint EK, "Differential expression of toll-like receptors in patients with irritable bowel syndrome" 106 : 329-336, 2011

39 Cario E, "Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease" 68 : 7010-7017, 2000

40 Uday C Ghoshal, "Development, Translation and Validation of Enhanced Asian Rome III Questionnaires for Diagnosis of Functional Bowel Diseases in Major Asian Languages: A Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report" 대한소화기 기능성질환∙운동학회 21 (21): 83-92, 2015

41 Stanislawowski M, "Decreased toll-like receptor-5 (TLR-5) expression in the mucosa of ulcerative colitis patients" 60 (60): 71-75, 2009

42 Zhou Y, "Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease" 10 : 2-, 2011

43 Bashashati M, "Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis" 26 : 1036-1048, 2014

44 Öhman L, "Crosstalk at the mucosal border: importance of the gut microenvironment in IBS" 12 : 36-49, 2015

45 Darkoh C, "Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome" 9 : e93144-, 2014

46 Liu Z, "Chemokine CXCL11 links microbial stimuli to intestinal inflammation" 164 : 396-406, 2011

47 Taché Y, "CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome" 141 : 1321-1330, 2004

48 Cario E, "Bacterial interactions with cells of the intestinal mucosa: toll-like receptors and NOD2" 54 : 1182-1193, 2005

49 Malinen E, "Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR" 100 : 373-382, 2005

50 McKernan DP, "Altered peripheral toll-like receptor responses in the irritable bowel syndrome" 33 : 1045-1052, 2011

51 Thompson-Chagoyán OC, "Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response" 24 : 339-352, 2005

52 Wong CK, "Activation profile of toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus" 159 : 11-22, 2010

53 진선희, "Activation of Toll-like Receptors 1, 2, 4, 5, and 7 on Human Melanocytes Modulate Pigmentation" 대한피부과학회 22 (22): 486-489, 2010

54 Dillon S, "A toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signalregulated kinase mitogen-activated protein kinase and c-fos in dendritic cells" 172 : 4733-4743, 2004